Kessler Exits Perrigo With Doors Open On Turnaround, Closed On Ireland, US Tax Disputes

At helm nearly five years with Perrigo continuing to navigate comprehensive turnaround with a target of returning to its historical profile of driving volume sales while keeping costs lower than is brand-name OTC drug competitors, he’s leaving at end of July.

• Source: Shutterstock

Soon after Murray Kessler joined Perrigo Company PLC as president and CEO in 2018, Ireland hit the firm “out of nowhere” with a €1.6bn ($1.9bn) tax assessment.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from HBW Insight